Skip to main content

Clinical and Translational Oncology

Ausgabe 7/2023

Inhalt (31 Artikel)

REVIEW ARTICLE

Investigation of the female infertility risk associated with anti-cancer therapy

Atiye Lavafian, Parmida Sadat Pezeshki, Nima Rezaei

REVIEW ARTICLE

The regulation roles of miRNAs in Helicobacter pylori infection

Ting Tong, You Zhou, Qiaoling Huang, Cui Xiao, Qinqin Bai, Bo Deng, Lili Chen

REVIEW ARTICLE

A new border for circadian rhythm gene NFIL3 in diverse fields of cancer

Lixuan Zeng, DongXin Chen, Yang Xue, Minghui Zhang, Yiqi Wu, Weiwei Yang

REVIEW ARTICLE

Progress of gut microbiome and its metabolomics in early screening of colorectal cancer

Lujia Zhou, Zhengting Jiang, Zhilin Zhang, Juan Xing, Daorong Wang, Dong Tang

REVIEW ARTICLE

The huge potential of targeting copper status in the treatment of colorectal cancer

Zhengting Jiang, Gengyu Sha, Wenjie Zhang, Zhilin Zhang, Tian Liu, Daorong Wang, Dong Tang

REVIEW ARTICLE

Relationship between HuR and tumor drug resistance

Qiancheng Ma, Qiliang Lu, Xiangxiang Lei, Jie Zhao, Wen Sun, Dongsheng Huang, Qing Zhu, Qiuran Xu

REVIEW ARTICLE

Potential roles of lncRNA-XIST/miRNAs/mRNAs in human cancer cells

Maryam Farzaneh, Ava Nasrolahi, Farhoodeh Ghaedrahmati, Tariq Masoodi, Sajad Najafi, Mohadeseh Sheykhi-Sabzehpoush, Mahrokh Abouali Gale Dari, Klaudia Radoszkiewicz, Shahab Uddin, Shirin Azizidoost, Seyed Esmaeil Khoshnam

REVIEW ARTICLE

Nanoparticles for cancer therapy: a review of influencing factors and evaluation methods for biosafety

Jinghua Li, Tao Wu, Shiman Li, Xinyan Chen, Zhiming Deng, Yong Huang

REVIEW ARTICLE

Mesenchymal stem cells-derived secretome and extracellular vesicles: perspective and challenges in cancer therapy and clinical applications

Jack Gemayel, Diana Chaker, Georges El Hachem, Melissa Mhanna, Rawad Salemeh, Colette Hanna, Frederic Harb, Ahmad Ibrahim, Alain Chebly, Charbel Khalil

Open Access SPECIAL ARTICLE

Sex differences in the diagnosis, treatment and prognosis of cancer: the rationale for an individualised approach

Ruth Vera, Oscar Juan-Vidal, María José Safont-Aguilera, Francisco Ayala de la Peña, Aránzazu González del Alba

RESEARCH ARTICLE

Effects of CpG sites methylation modification of HPV16 integration essential gene on the proliferation of cervical cancer cells

Chongyu Guo, Zhaoxia Ran, Decheng Li, Jingjing Zhu, Yushu Peng, Weihong Zhao, Li Song, Yuanjing Lyv, Zhiqiang Tian, Jintao Wang, Ling Ding

RESEARCH ARTICLE

Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03

Jesus Garcia-Donas, Alicia Hurtado, Laia Garrigos, Ana Santaballa, Andres Redondo, Laura Vidal, Nuria Lainez, Eva Guerra, Victor Rodriguez, Juan Cueva, Isabel Bover, Isabel Palacio, Maria Jesus Rubio, Mario Prieto, Jose Antonio Lopez-Guerrero, Juan Francisco Rodriguez-Moreno, Zaida Garcia-Casado, Elena Garcia-Martinez, Alvaro Taus, Ignacio Pérez de Castro, Paloma Navarro, Enrique Grande

RESEARCH ARTICLE

Analysis of angiogenesis-related subtypes of hepatocellular carcinoma and tumor microenvironment infiltration feature in hepatocellular carcinoma

Wang Li, Ruichao Wu, Shengning Zhang, Yingpeng Zhao, Laibang Li, Zongqiang Hu, Qiuming Su, Yuanyi Mang, Xibing Zhang, Yun Dong, Kepu Zheng, Jianghua Ran, Li Li

RESEARCH ARTICLE

125I seed implantation enhances arsenic trioxide-induced apoptosis and anti-angiogenesis in lung cancer xenograft mice

Zheng-Hong Chen, Yi-Li Zhang, Bin Yuan, Wen-Juan Chen, Guang-Yan Lei, Le Han

Research Article

Radiation therapy for vulvar cancer: consensus guidelines of the GINECOR working group of the Spanish Society of Radiation Oncology. Part 1: clinical recommendations

Sofia Cordoba Largo, Isabel Rodriguez Rodriguez, Silvia Rodriguez Villalba, Dina Najjari Jamal, Javier Anchuelo Latorre, Francisco Celada Álvarez, Sonia Garcia Cabezas, Cristina de la Fuente Alonso, Luz Couselo Paniagua, Irene Martínez Montesinos, Elena Villafranca Iturre, Belén Belinchón Olmeda, Dolores Farga Albiol, Paola Andrea Navarrete Solano, María Sánchez Belda

Research Article

Radiation therapy for vulvar cancer: consensus technical guidelines of the GINECOR working group of the Spanish Society of Radiation Oncology. Part 2: radiotherapy recommendations

Sofia Cordoba Largo, Isabel Rodriguez Rodriguez, Silvia Rodriguez Villalba, Dina Najjari Jamal, Javier Anchuelo Latorre, Francisco Celada Alvarez, Sonia Garcia Cabezas, Cristina de la Fuente Alonso, Luz Couselo Paniagua, Irene Martinez Montesinos, Elena Villafranca Iturre, Belen Belinchon Olmeda, Dolores Farga Albiol, Paola Andrea Navarrete Solano, Maria Sanchez Belda

RESEARCH ARTICLE

JHDM1D-AS1-driven inhibition of miR-940 releases ARTN expression to induce breast carcinogenesis

Yonggang Zuo, Mingde Ma, Yuqing Wen, Liang Chang, Changping Qu

RESEARCH ARTICLE

Ezrin regulates the progression of NSCLC by YAP and PD-L1

Fan Bu, Yeping Zhang, Ning Zhao, Xiaoai Tian, Yirong Xu

RESEARCH ARTICLE

ENO1 promotes immunosuppression and tumor growth in pancreatic cancer

Chen Kai Huang, Lei Lv, Huanliang Chen, Ying Sun, Yong Ping

Correction

Correction to: Radiation therapy for vulvar cancer: consensus guidelines of the GINECOR working group of the Spanish Society of Radiation Oncology. Part 1: clinical recommendations

Sofia Cordoba Largo, Isabel Rodriguez Rodriguez, Silvia Rodriguez Villalba, Dina Najjari Jamal, Javier Anchuelo Latorre, Francisco Celada Álvarez, Sonia Garcia Cabezas, Cristina de la Fuente Alonso, Luz Couselo Paniagua, Irene Martínez Montesinos, Elena Villafranca Iturre, Belén Belinchón Olmeda, Dolores Farga Albiol, Paola Andrea Navarrete Solano, María Sánchez Belda

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.